Tag:#GW Pharma

European Cannabis Round-Up; GW Pharma’s Cannabis Pipeline, Irish CBD In Court, UK Medical Cannabis Price Row, Italian Referendum, Poland And Malta

GW Pharmaceuticals has released further details of its cannabis development pipeline.  With Epidiolex approved in the US last year it is also expecting approval for...

UK Cannabis Cultivation Staff In Short-Supply Due To Post-Brexit Seasonal Labour Shake-UP

CHANGES to immigration policy post-Brexit has resulted in a shortage of seasonal labour at UK-based medicinal cannabis cultivation sites, claims the company that owns...

UK Cannabis Firm GW Pharmaceuticals Honoured By Her Majesty For Its Innovation

LEADING UK cannabis company GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in recognition of its ground-breaking work in creating the world’s...

Markets: LSE Debutants Soar, Meme Stocks, Generation Y, GW Pharma, Pharma & The Green Rush

THE last few weeks have witnessed a wild ride for global cannabis stocks reminiscent of some of the earlier bubbles experienced by the sector. So...

World’s Largest Cannabis Deal Sees UK Firm GW Pharma Bought For $7.2bn

IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn. The deal will be the biggest ever transaction in...

Markets: World’s Leading Drug Companies Finding A Way Into Cannabis.

THE emerging cannabis industry is moving up the agenda for the pharmaceutical industry with two significant deals announced in the last few months. Over the...

New UK Cannabis Fund Closes In On Its First $75m Investment

ONE of the UK’s first cannabis investment funds is being backed by two of the industry’s global leaders as it closes in on its...

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...
- Advertisement -spot_imgspot_img

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Must read